409 related articles for article (PubMed ID: 26408171)
1. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
2. The use of cannabinoids as anticancer agents.
Velasco G; Hernández-Tiedra S; Dávila D; Lorente M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():259-66. PubMed ID: 26071989
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour actions of cannabinoids.
Hinz B; Ramer R
Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
6. The Endocannabinoid System: A Target for Cancer Treatment.
Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids as Guardians of Metastasis.
Tegeder I
Int J Mol Sci; 2016 Feb; 17(2):230. PubMed ID: 26875980
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
9. Anticancer mechanisms of cannabinoids.
Velasco G; Sánchez C; Guzmán M
Curr Oncol; 2016 Mar; 23(2):S23-32. PubMed ID: 27022311
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system in cancer-potential therapeutic target?
Flygare J; Sander B
Semin Cancer Biol; 2008 Jun; 18(3):176-89. PubMed ID: 18249558
[TBL] [Abstract][Full Text] [Related]
11. Targeting the endocannabinoid system: future therapeutic strategies.
Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
[TBL] [Abstract][Full Text] [Related]
12. [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
Bifulco M; Di Marzo V
Recenti Prog Med; 2003 May; 94(5):194-8. PubMed ID: 12723496
[TBL] [Abstract][Full Text] [Related]
13. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
14. Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
Pisanti S; Malfitano AM; Grimaldi C; Santoro A; Gazzerro P; Laezza C; Bifulco M
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):117-31. PubMed ID: 19285265
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor systems: therapeutic targets for tumour intervention.
Jones S; Howl J
Expert Opin Ther Targets; 2003 Dec; 7(6):749-58. PubMed ID: 14640910
[TBL] [Abstract][Full Text] [Related]
16. The Endocannabinoid System as a Therapeutic Target in Glaucoma.
Cairns EA; Baldridge WH; Kelly ME
Neural Plast; 2016; 2016():9364091. PubMed ID: 26881140
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
[TBL] [Abstract][Full Text] [Related]
18. The evolution of cannabinoid receptors in cancer.
Pennant NM; Hinton CV
WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids as Anticancer Drugs.
Ramer R; Hinz B
Adv Pharmacol; 2017; 80():397-436. PubMed ID: 28826542
[TBL] [Abstract][Full Text] [Related]
20. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
